BioSpace News Archive

Shorter hospital stays, fewer complications and better patient results are just a few metrics used to rank Mercy as one of the top five large health systems in the nation, alongside Mayo Clinic.

Egalet Corporation announced that its first quarter 2018 financial results will be released on Tuesday, May 8, 2018.

REVOLUTION Medicines, Inc. announced it has raised $56 million in a Series B financing to support its ongoing R&D programs and general business activities.

FormFast is pleased to announce long-time customer, War Memorial Hospital, is expanding FormFast to their ambulatory facilities.

Intec Pharma LTD (NASDAQ, TASE: NTEC) (“Intec” or “the Company”) today announces that data collected from two Phase 1 studies of its proprietary Accordion Pill Carbidopa/Levodopa (AP-CD/LD) for Parkinson’s disease were highlighted in a poster presentation at the American Academy of Neurology 2018 Annual Meeting (AAN 2018) underway in Los Angeles

Patisiran Reduced the Composite Rate of All-Cause Hospitalization and Mortality by Approximately 50 Percent, Relative to Placebo

Company is targeting upstream aspects of native protein degradation pathways to develop new therapies for cancer

China Biologic Products Holdings, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company will release first quarter 2018 financial results on Friday, May 4, 2018 after market close.

Sales of $8.3 billion, up 7.7 percent year-on-year

Frost & Sullivan recognizes CarePassport with the 2017 North American Visionary Innovation Leadership Award for its mobile-based, data-driven patient engagement solution that digitizes patient-clinician collaboration and supports more informed decision-making.